This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Innovations by Charles David Hartley: A Pioneer in Antiviral Research
Introduction
Charles David Hartley, an inventive mind hailing from Stevenage, GB, has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antiviral agents. With a remarkable portfolio that includes four patents, Hartley stands out as a key figure in innovative research aimed at combating viral infections.
Latest Patents
Hartley’s latest patents focus on the development of 1-acyl-pyrrolidine derivatives for the treatment of viral infections. These compounds are described as anti-viral agents represented by a complex formula which includes various substituents that enhance their efficacy. In addition, he has developed 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as inhibitors for Hepatitis C Virus (HCV), showcasing his dedication to creating novel antiviral solutions. The formulations include pharmaceutical compositions based on these compounds and methodologies for their application in treating HCV, demonstrating Hartley’s impact in this critical area of healthcare.
Career Highlights
Throughout his career, Hartley has been associated with renowned corporations such as Glaxo Group Limited and SmithKline Beecham Corporation. His work at these esteemed organizations has enabled him to collaborate and innovate alongside some of the brightest minds in the field.
Collaborations
Working alongside notable colleagues like Alan Naylor and Jeremy John Payne, Hartley has been able to combine his expertise with the insights of other professionals, further enhancing the quality and impact of his research. This collaborative effort has contributed significantly to the advancement of antiviral therapies and the overall knowledge in this domain.
Conclusion
Charles David Hartley continues to be a driving force in antiviral research with his innovative patents and collaborations. His contributions are invaluable in the ongoing fight against viral infections, marking him as an influential inventor in the realm of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile